Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ronda Henry-Tillman

Concepts (256)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
39
2024
1187
4.760
 Why?
Early Detection of Cancer
6
2020
164
2.390
 Why?
Ultrasonography, Mammary
8
2020
61
2.060
 Why?
Colorectal Neoplasms
4
2018
255
1.530
 Why?
Mass Screening
3
2020
348
1.530
 Why?
Healthcare Disparities
3
2017
279
1.100
 Why?
Mastectomy
13
2019
142
1.090
 Why?
Mastectomy, Segmental
7
2018
93
1.070
 Why?
Sentinel Lymph Node Biopsy
10
2015
118
1.020
 Why?
Community Health Planning
3
2018
27
0.990
 Why?
Ultrasonography, Interventional
5
2020
137
0.850
 Why?
Biopsy, Needle
10
2015
182
0.840
 Why?
Focus Groups
1
2024
190
0.830
 Why?
Neoplasm Staging
14
2024
749
0.820
 Why?
Biopsy, Large-Core Needle
3
2020
32
0.820
 Why?
Female
55
2024
26829
0.780
 Why?
Genetic Counseling
1
2022
40
0.770
 Why?
Health Status Disparities
3
2015
196
0.760
 Why?
Neoplasms
5
2015
1233
0.760
 Why?
Lymph Nodes
7
2015
258
0.750
 Why?
Patient Education as Topic
1
2024
314
0.730
 Why?
Image Interpretation, Computer-Assisted
1
2020
105
0.690
 Why?
Middle Aged
40
2024
12356
0.670
 Why?
Image-Guided Biopsy
2
2020
33
0.660
 Why?
Hematoma
4
2018
64
0.650
 Why?
Surgery, Computer-Assisted
2
2018
54
0.640
 Why?
Polymorphism, Single Nucleotide
2
2018
484
0.630
 Why?
Humans
60
2024
50201
0.620
 Why?
Mandatory Programs
1
2018
21
0.600
 Why?
Adiposity
1
2019
132
0.590
 Why?
Faculty, Medical
3
2021
92
0.580
 Why?
Health Care Costs
1
2018
168
0.570
 Why?
Aged
31
2024
9505
0.570
 Why?
Adult
32
2024
13486
0.560
 Why?
Insurance Coverage
1
2018
110
0.550
 Why?
Disease Management
1
2018
175
0.540
 Why?
Diagnostic Imaging
1
2018
179
0.530
 Why?
Minority Groups
3
2015
130
0.520
 Why?
Arkansas
9
2018
1988
0.510
 Why?
Retrospective Studies
19
2022
6190
0.480
 Why?
Physicians
1
2018
229
0.470
 Why?
Health Planning Councils
1
2014
6
0.460
 Why?
Community-Based Participatory Research
2
2015
197
0.440
 Why?
Health Policy
1
2014
151
0.420
 Why?
Rural Population
1
2017
551
0.410
 Why?
Follow-Up Studies
11
2018
2188
0.410
 Why?
Aged, 80 and over
14
2018
3158
0.400
 Why?
Qualitative Research
3
2024
337
0.390
 Why?
Community Networks
2
2015
50
0.390
 Why?
Community-Institutional Relations
1
2011
46
0.390
 Why?
Primary Health Care
2
2024
363
0.380
 Why?
Carcinoma, Ductal, Breast
4
2015
91
0.370
 Why?
Carcinoma, Lobular
2
2015
33
0.370
 Why?
Population Surveillance
1
2012
161
0.360
 Why?
Physicians, Women
2
2021
22
0.360
 Why?
Neoplasm Recurrence, Local
6
2014
630
0.340
 Why?
Women's Health
1
2010
82
0.330
 Why?
Health Education
2
2008
153
0.330
 Why?
Needs Assessment
2
2024
133
0.330
 Why?
Medical Oncology
1
2010
96
0.320
 Why?
Breast Diseases
4
2018
27
0.310
 Why?
Nipples
5
2013
33
0.290
 Why?
Schools, Medical
2
2020
70
0.290
 Why?
Health Knowledge, Attitudes, Practice
1
2012
489
0.290
 Why?
Axilla
6
2015
91
0.290
 Why?
Socioeconomic Factors
3
2018
584
0.290
 Why?
Morbidity
2
2018
132
0.290
 Why?
Health Services Accessibility
1
2011
420
0.270
 Why?
Physician-Patient Relations
2
2012
143
0.270
 Why?
Catheter Ablation
4
2014
122
0.260
 Why?
Mammaplasty
3
2013
44
0.260
 Why?
Prognosis
9
2024
1963
0.250
 Why?
Mentors
1
2006
55
0.250
 Why?
Lymphatic Metastasis
7
2015
226
0.250
 Why?
Survivors
2
2024
120
0.250
 Why?
Occult Blood
2
2017
22
0.240
 Why?
United States
7
2022
4898
0.240
 Why?
Young Adult
5
2024
4052
0.230
 Why?
Magnetic Resonance Imaging
5
2014
1529
0.230
 Why?
Referral and Consultation
2
2024
284
0.220
 Why?
Education, Medical, Graduate
2
2022
213
0.210
 Why?
Technetium Tc 99m Sulfur Colloid
4
2008
31
0.200
 Why?
Male
13
2022
25572
0.200
 Why?
Empathy
1
2002
46
0.200
 Why?
Problem-Based Learning
1
2002
47
0.190
 Why?
Atrial Fibrillation
1
2024
182
0.190
 Why?
Emotions
1
2023
165
0.190
 Why?
Breast
2
2020
86
0.190
 Why?
Genetic Testing
1
2022
119
0.190
 Why?
Democratic Republic of the Congo
1
2020
4
0.190
 Why?
Dermatologic Surgical Procedures
3
2013
34
0.180
 Why?
Counseling
1
2022
132
0.180
 Why?
Combined Modality Therapy
4
2018
639
0.180
 Why?
Feasibility Studies
2
2020
383
0.180
 Why?
Biopsy, Fine-Needle
1
2020
108
0.170
 Why?
Research Support as Topic
1
2020
45
0.170
 Why?
Students, Medical
1
2002
159
0.170
 Why?
General Surgery
1
2021
107
0.170
 Why?
Surgical Flaps
2
2019
114
0.160
 Why?
Obesity
1
2008
1112
0.160
 Why?
Prospective Studies
10
2024
2396
0.160
 Why?
Incidence
2
2024
1000
0.160
 Why?
Patient Satisfaction
2
2019
280
0.160
 Why?
Radiopharmaceuticals
4
2008
205
0.150
 Why?
Adipose Tissue
1
2019
191
0.140
 Why?
Logistic Models
2
2018
901
0.140
 Why?
Diagnosis, Differential
1
2020
1041
0.140
 Why?
Rural Health
1
2017
88
0.140
 Why?
Lymphatic Vessels
2
2008
53
0.140
 Why?
Odds Ratio
1
2018
548
0.140
 Why?
Internship and Residency
1
2022
443
0.130
 Why?
Zambia
3
2024
3
0.130
 Why?
Mammography
1
2016
99
0.130
 Why?
Rural Health Services
1
2018
168
0.130
 Why?
Cytodiagnosis
2
2013
42
0.130
 Why?
Genetic Predisposition to Disease
1
2018
508
0.130
 Why?
Risk Assessment
2
2018
1255
0.120
 Why?
Case-Control Studies
1
2018
1145
0.120
 Why?
Cross-Sectional Studies
3
2021
1580
0.120
 Why?
National Cancer Institute (U.S.)
1
2015
31
0.120
 Why?
Survival Rate
1
2017
906
0.120
 Why?
Uterine Cervical Neoplasms
1
2017
277
0.120
 Why?
Algorithms
1
2018
615
0.120
 Why?
Career Mobility
2
2021
28
0.110
 Why?
Patient Care Planning
1
2013
67
0.110
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
2013
43
0.110
 Why?
Monitoring, Intraoperative
3
2014
54
0.100
 Why?
Education, Medical
2
2006
112
0.100
 Why?
Sigmoidoscopy
1
2012
10
0.100
 Why?
Reagent Kits, Diagnostic
1
2012
18
0.100
 Why?
Health Services
1
2012
65
0.100
 Why?
Colonoscopy
1
2012
97
0.090
 Why?
Lymph Node Excision
4
2008
138
0.090
 Why?
Feces
1
2012
131
0.090
 Why?
Reproducibility of Results
1
2015
1195
0.090
 Why?
Treatment Outcome
9
2017
5203
0.090
 Why?
Receptors, Estrogen
2
2015
130
0.090
 Why?
Lymphedema
2
2008
43
0.090
 Why?
Pancreatic Neoplasms
1
2013
209
0.090
 Why?
Fructose
1
2010
22
0.090
 Why?
Clinical Competence
1
2013
397
0.090
 Why?
Patient Compliance
1
2012
230
0.090
 Why?
Registries
1
2013
527
0.090
 Why?
Carbon
1
2010
55
0.090
 Why?
History, 21st Century
1
2010
56
0.090
 Why?
Risk Factors
3
2024
3644
0.090
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1000
0.080
 Why?
Carcinoma in Situ
2
2006
73
0.080
 Why?
Patient Acceptance of Health Care
1
2012
337
0.080
 Why?
Delivery of Health Care
1
2011
308
0.070
 Why?
Models, Theoretical
2
2006
174
0.070
 Why?
Prochlorperazine
1
2006
6
0.070
 Why?
Postoperative Nausea and Vomiting
1
2006
20
0.070
 Why?
Education, Medical, Continuing
1
2006
68
0.070
 Why?
Antiemetics
1
2006
32
0.070
 Why?
Sensitivity and Specificity
3
2004
871
0.070
 Why?
Receptor, erbB-2
1
2006
74
0.070
 Why?
Body Weights and Measures
1
2005
17
0.060
 Why?
Biopsy
2
2004
592
0.060
 Why?
Predictive Value of Tests
2
2013
921
0.060
 Why?
Intraoperative Care
2
2003
52
0.060
 Why?
Gadolinium
1
2005
42
0.060
 Why?
Interprofessional Relations
1
2006
84
0.060
 Why?
Tissue Expansion Devices
1
2004
3
0.060
 Why?
Neuromuscular Agents
1
2004
7
0.060
 Why?
Neoadjuvant Therapy
2
2017
119
0.060
 Why?
Botulinum Toxins, Type A
1
2004
13
0.060
 Why?
Imaging, Three-Dimensional
1
2005
152
0.060
 Why?
Life Expectancy
1
2024
33
0.060
 Why?
Contrast Media
1
2005
186
0.060
 Why?
Cytological Techniques
1
2003
14
0.060
 Why?
Anthracyclines
1
2024
29
0.060
 Why?
Neoplasms, Multiple Primary
1
2003
43
0.050
 Why?
Neoplasm Grading
2
2014
123
0.050
 Why?
Pain, Postoperative
1
2004
160
0.050
 Why?
Preoperative Care
3
2014
167
0.050
 Why?
Surgical Instruments
1
2002
27
0.050
 Why?
Humanism
1
2002
8
0.050
 Why?
Life Change Events
1
2002
36
0.050
 Why?
Foreign-Body Migration
1
2002
32
0.050
 Why?
Confidence Intervals
1
2002
155
0.050
 Why?
Career Choice
1
2002
111
0.050
 Why?
Program Development
1
2002
162
0.050
 Why?
Sexism
1
2021
10
0.050
 Why?
Image Processing, Computer-Assisted
1
2002
243
0.050
 Why?
Leadership
1
2021
100
0.040
 Why?
Neoplasm Invasiveness
2
2010
269
0.040
 Why?
Vacuum
2
2011
13
0.040
 Why?
Curriculum
1
2002
397
0.040
 Why?
Stereotaxic Techniques
2
2010
37
0.040
 Why?
Angiopoietin-2
1
2017
15
0.040
 Why?
Angiopoietin-1
1
2017
16
0.040
 Why?
Receptor, TIE-2
1
2017
16
0.040
 Why?
Fibroblast Growth Factor 2
1
2017
34
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
46
0.030
 Why?
Gene Frequency
1
2017
96
0.030
 Why?
Injections, Intralesional
2
2008
31
0.030
 Why?
Matrix Metalloproteinase 9
1
2017
87
0.030
 Why?
Adolescent
3
2013
6459
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
183
0.030
 Why?
Guidelines as Topic
1
2016
110
0.030
 Why?
Neovascularization, Pathologic
1
2017
153
0.030
 Why?
Regression Analysis
1
2017
395
0.030
 Why?
Coloring Agents
2
2007
70
0.030
 Why?
Radionuclide Imaging
2
2007
116
0.030
 Why?
Educational Status
1
2016
225
0.030
 Why?
Genotype
1
2017
542
0.030
 Why?
Taxoids
1
2015
37
0.030
 Why?
Receptors, Progesterone
1
2015
63
0.030
 Why?
Cohort Studies
2
2011
1414
0.030
 Why?
Cyclophosphamide
1
2015
164
0.030
 Why?
Touch
1
2013
25
0.030
 Why?
Ultrasonography, Doppler
1
2014
41
0.030
 Why?
Carcinoma
1
2015
139
0.030
 Why?
Angiogenesis Inhibitors
1
2015
182
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2015
224
0.030
 Why?
Disease-Free Survival
1
2014
450
0.030
 Why?
Kaplan-Meier Estimate
1
2014
463
0.030
 Why?
Cicatrix
1
2011
40
0.020
 Why?
Microscopy, Phase-Contrast
1
2010
13
0.020
 Why?
Plant Lectins
1
2010
8
0.020
 Why?
Glycosylation
1
2010
102
0.020
 Why?
Substrate Specificity
1
2010
192
0.020
 Why?
Actins
1
2010
115
0.020
 Why?
Tumor Cells, Cultured
1
2010
462
0.020
 Why?
Cell Movement
1
2010
245
0.020
 Why?
Breast Neoplasms, Male
1
2009
7
0.020
 Why?
Pilot Projects
1
2011
703
0.020
 Why?
Arm
1
2008
47
0.020
 Why?
Phenotype
1
2010
732
0.020
 Why?
Cost-Benefit Analysis
1
2008
270
0.020
 Why?
Positron-Emission Tomography
1
2008
288
0.020
 Why?
Administration, Rectal
1
2006
10
0.020
 Why?
Cell Line, Tumor
1
2010
1390
0.020
 Why?
Probability
1
2006
164
0.020
 Why?
Primary Prevention
1
2006
44
0.020
 Why?
Drug Administration Schedule
1
2006
369
0.020
 Why?
Administration, Oral
1
2006
432
0.020
 Why?
Carcinoma, Ductal
1
2004
9
0.020
 Why?
Tissue Expansion
1
2004
4
0.020
 Why?
Pectoralis Muscles
1
2004
6
0.020
 Why?
Rectus Abdominis
1
2004
7
0.020
 Why?
Spasm
1
2004
9
0.010
 Why?
Laser Coagulation
1
2004
26
0.010
 Why?
Multivariate Analysis
1
2006
581
0.010
 Why?
Cryosurgery
1
2004
36
0.010
 Why?
Sampling Studies
1
2004
37
0.010
 Why?
Statistics, Nonparametric
1
2004
193
0.010
 Why?
Chi-Square Distribution
1
2004
280
0.010
 Why?
Injections
1
2003
57
0.010
 Why?
Pain Measurement
1
2004
246
0.010
 Why?
Ultrasonography
1
2004
438
0.010
 Why?
Dose-Response Relationship, Drug
1
2006
1356
0.010
 Why?
Length of Stay
1
2004
627
0.010
 Why?
Reoperation
1
2002
454
0.010
 Why?
Analgesics, Opioid
1
2004
562
0.010
 Why?
Henry-Tillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (256) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department